Aytu BioScience, Inc. (Nasdaq: AYTU) to Ring The Nasdaq Stock Market Closing Bell
October 19 2017 - 10:18AM
What: Aytu BioScience, Inc.
(Nasdaq:AYTU), a specialty life sciences company focused on global
commercialization of novel products in the field of urology, will
visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Josh Disbrow, Chairman &
CEO, will ring the Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Friday, October 20, 2017 – 3:45 p.m. to
4:00 p.m. ET
Aytu BioScience Contact:Allison
Halte303-996-3681ahalte@aytubio.com
Nasdaq MarketSite Media Contact:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Aytu BioScience, Inc.Aytu BioScience is a
commercial-stage specialty life sciences company focused on global
commercialization of novel products in the field of urology, with a
focus on products addressing vitality, sexual wellness, and
reproductive health. The Company currently markets two prescription
products in the U.S.: Natesto®, the first and only FDA-approved
nasal formulation of testosterone for men with hypogonadism (low
testosterone, or “Low T”) and ProstaScint® (capromab pendetide),
the only FDA-approved imaging agent specific to prostate specific
membrane antigen (PSMA) for prostate cancer detection and staging.
Additionally, Aytu is developing MiOXSYS®, a novel, rapid semen
analysis system with the potential to become a standard of care for
the diagnosis and management of male infertility caused by
oxidative stress. MiOXSYS® is commercialized outside the U.S. where
it is a CE Marked, Health Canada cleared product, and Aytu is
planning U.S.-based clinical trials in pursuit of 510k medical
device clearance by the FDA. Aytu’s strategy is to continue
building its portfolio of revenue-generating products, leveraging
its focused commercial team and expertise to build leading brands
within growing markets. For more information visit aytubio.com.
Aytu also now owns wholly-owned subsidiary Aytu Women’s Health
(formerly Nuelle, Inc.), a personal health and wellness company
focused on women’s sexual wellbeing and intimacy. Aytu Women’s
Health markets Fiera, a personal care device for women that is
scientifically proven to enhance physical arousal and sexual
desire. Fiera is a consumer device and is not intended to treat,
mitigate, or cure any disease or medical condition. For more
information about the Fiera personal care device visit
fiera.com.
About Nasdaq:Nasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,900 total listings
with a market value of approximately $12 trillion. To learn more,
visit: http://business.nasdaq.com
-NDAQA-
AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Mar 2024 to Apr 2024
AYTU BioPharma (NASDAQ:AYTU)
Historical Stock Chart
From Apr 2023 to Apr 2024